Inventor · disambiguated record
James M. Siedlecki
Also filed as: SIEDLECKI JAMES · SIEDLECKI JAMES M · SIEDLECKI JAMES MICHAEL
9 granted patents·3 pending applications·27 citations·filing 2004–2021
82Inventor score
Files withACTIVBIOTICS INC3ACTIVBIOTICS PHARMA LLC3IMMUNOMOLECULAR THERAPEUTICS INC2INNATE BIOTHERAPEUTICS LLC2COLLABORATIVE MEDICINAL DEV LLC1
Top patents by PatentIndex Score
12 records- 0183US7547692B2Rifamycin analogs and uses thereofACTIVBIOTICS PHARMA LLC·Filed 2006·Granted Jun 16, 2009·10 cites·18 claims
- 0278US7271165B2Rifamycin analogs and uses thereofACTIVBIOTICS INC·Filed 2004·Granted Sep 18, 2007·12 cites·6 claims
- 0374US10266609B2Immunomodulating beta-1,6-D-glucansINNATE BIOTHERAPEUTICS LLC·Filed 2015·Granted Apr 23, 2019·2 cites·19 claims
- 0474US7488726B2Rifamycin analogs and uses thereofACTIVBIOTICS PHARMA LLC·Filed 2006·Granted Feb 10, 2009·2 cites·17 claims
- 0570US7494991B2Rifamycin analogs and uses thereofACTIVBIOTICS PHARMA LLC·Filed 2007·Granted Feb 24, 2009·1 cites·21 claims
- 0653US11945790B2Compounds and methods for treating autoimmune disorders by targeting HLA-DQ2IMMUNOMOLECULAR THERAPEUTICS INC·Filed 2021·Granted Apr 2, 2024·0 cites·15 claims
- 0753US2010273765A1Rifamycin analogs and uses thereofACTIVBIOTICS INC·Filed 2007·Application pending·0 cites
- 0851US7220738B2Rifamycin analogs and uses thereofACTIVBIOTICS INC·Filed 2004·Granted May 22, 2007·0 cites·12 claims
- 0944US11939300B2Compounds and methods for treating autoimmune disorders by targeting HLA-DQ2IMMUNOMOLECULAR THERAPEUTICS INC·Filed 2021·Granted Mar 26, 2024·0 cites·17 claims
- 1040US11865135B2ß-1,6-glucan therapeutic antibody conjugatesINNATE BIOTHERAPEUTICS LLC·Filed 2017·Granted Jan 9, 2024·0 cites·17 claims
- 1137US2022144826A1Heteroaromatic and Heterobicyclic Aromatic Derivatives for the Treatment of Ferroptosis-Related DisordersCOLLABORATIVE MEDICINAL DEV LLC·Filed 2020·Application pending·0 cites
- 1229US2018154014A1Beta-1,6-glucan cetuximab antibody conjugatesIMMUNEXCITE INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James M. Siedlecki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →